Asabys Partners, alongside Alta Life Sciences, BPI France, Fund+ and Ysios Capital Partners, have invested in a €30m series-A round for drug development company Ona Therapeutics.
Fund has made four platform investments and backs European digital and technology-based companies
Toni Gillespie joins as chief of talent, while Elisabetta Ricci joins as chief of staff
GP backed the business – then called Ryds Bilglas – via Nordic Capital VIII in 2018
Auction of the Italian producer of natural flavours and ingredients is expected to launch in early 2022